VANCOUVER, BC, Sept. 29,
2022 /CNW/ - Numinus Wellness
Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF),
a mental health care company advancing innovative treatments and
safe, evidence-based psychedelic-assisted therapies, today
announced that it will participate in the Cantor Neurology &
Psychiatry Conference to be held at The Ritz-Carlton in
San Francisco on October 6-7, 2022.
Payton Nyquvest, Founder and CEO
of Numinus, will participate in the Digital-Pharma and a New Way
of Thinking for NeuroPsych panel on Friday, October 7th at 9:00 a.m. PT.
In addition, Numinus will participate in the Cantor Symposium on
Mental Health Clinics on Tuesday, October
11, 2022. Mr. Nyquvest will participate in a virtual
fireside chat with Pablo Zuanic,
Cantor Research Analyst, at 11:00 a.m.
ET / 8:00 a.m. PT. To attend,
please register here:
https://us06web.zoom.us/webinar/register/WN_j0ChDwu_Tn6EFJfMUYjfqA
For more information about the conference, or to schedule a
one-on-one meeting with Numinus' management, please contact your
appropriate Cantor representative directly, or send an email to
KCSA Strategic Communications NuminusIR@kcsa.com.
About Numinus
Numinus Wellness (TSX: NUMI) helps
people to heal and be well through the development and delivery of
innovative mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model - including
psychedelic production, research and clinic care - is at the
forefront of a transformation aimed at healing rather than managing
symptoms for depression, anxiety, trauma, pain and substance use.
At Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice and building the
foundation for a healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter, and Instagram.
Forward-looking statements
Statements and other
information contained in this press release about anticipated
future events constitute forward-looking statements.
Forward-looking statements are often, but not always, identified by
the use of words such as "seek", "anticipate", "believe", "plan",
"estimate", "expect" and "intend" and statements that an event
"may", "will", "should", "could" or "might" occur or other similar
expressions. Forward-looking statements are subject to risks and
uncertainties and other factors that could cause actual results to
differ materially from those contained in the forward-looking
statements. Forward-looking statements are based on estimates and
opinions of management at the date the statements are made. The
Company does not undertake any obligation to update forward-looking
statements even if circumstances or management's estimates or
opinions should change except as required by applicable laws.
Investors should not place undue reliance on forward-looking
statements.
View original
content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-cantor-neurology--psychiatry-conference-on-october-6-7-2022-301637068.html
SOURCE Numinus Wellness Inc.